Spectrum-Effect Relationships Between the Bioactive Ingredient of Syringa oblata Lindl. Leaves and Its Role in Inhibiting the Biofilm Formation of Streptococcus suis
Lindl. ( ) has been used in herbal medicines for treating bacterial diseases. It is also thought to inhibit ( ) biofilm formation. However, due to the inherent nature of the complexity in its chemical properties, it is difficult to understand the possible bioactive ingredients of The spectrum-effect...
Saved in:
Published in | Frontiers in pharmacology Vol. 9; p. 570 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
05.06.2018
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Lindl. (
) has been used in herbal medicines for treating bacterial diseases. It is also thought to inhibit
(
) biofilm formation. However, due to the inherent nature of the complexity in its chemical properties, it is difficult to understand the possible bioactive ingredients of
The spectrum-effect relationships method was applied to screen the main active ingredients in
obtained from Heilongjiang Province based on gray relational analysis. The results revealed that Sub-MICs obtained from 10 batches of
could inhibit biofilm formation by
. Gray relational analysis revealed variations in the contents of 15 main peaks and rutin was discovered to be the main active ingredient. Then, the function of rutin was further verified by inhibiting
biofilm formation using crystal violet staining. Computational studies revealed that rutin may target the chloramphenicol acetyltransferase protein in the biofilm formation of
In conclusion, this study revealed that the spectrum-effect relationships and computational studies are useful tools to associate the active ingredient with the potential anti-biofilm effects of
. Here, our findings would provide foundation for the further understanding of the mechanism of
intervention in biofilm formation. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology Reviewed by: Wei Li, Toho University, Japan; Linlin Lu, International Institute for Translational Chinese Medicine, China; Shuai Ji, Xuzhou Medical College, China Edited by: Min Ye, Peking University, China These authors have contributed equally to this work and shared first authorship. |
ISSN: | 1663-9812 1663-9812 |
DOI: | 10.3389/fphar.2018.00570 |